ANALYZING AND MANAGING RISKS IN LIFE SCIENCES RESEARCH

Similar documents
ANALYZING AND MANAGING RISKS IN LIFE SCIENCES RESEARCH

ANALYZING AND MANAGING RISKS IN LIFE SCIENCES RESEARCH

OIE Situation Report for Highly Pathogenic Avian Influenza

OIE Situation Report for Avian Influenza

OIE Situation Report for Highly Pathogenic Avian Influenza

Contribution of avian influenza data through OFFLU network

OIE Situation Report for Highly Pathogenic Avian Influenza

Outbreak evaluation of highly pathogenic avian influenza in Bangladesh. Mymensingh *Corresponding author:

SCIENTIFIC DISCUSSION

Early Diagnosis: A Critical Step in Bird Flu Prevention

VIROLOGY OF INFLUENZA. Subtypes: A - Causes outbreak B - Causes outbreaks C - Does not cause outbreaks

INFORMATION NOTE ON AVIAN INFLUENZA AND MIGRATORY BIRDS

OIE Situation Report for Avian Influenza

Avian Influenza: Armageddon or Hype? Bryan E. Bledsoe, DO, FACEP The George Washington University Medical Center

OIE Situation Report for Avian Influenza

OIE Situation Report for Avian Influenza


INFLUENZA-2 Avian Influenza

Avian Influenza: Current situation and future challenges

CENSA-IZSVE: OIE TWINNING PROJECT on AVIAN INFLUENZA and NEWCASTLE DISEASE ( ) Marco De Nardi N. Micoli; MS. Beato; C.

OIE Situation Report for Avian Influenza

Agricultural Outlook Forum Presented: February 16, 2006 THE CURRENT STATE OF SCIENCE ON AVIAN INFLUENZA

SECOND FAO/OIE REGIONAL MEETING ON AVIAN INFLUENZA CONTROL IN ASIA Ho Chi Minh City, Vietnam, February 2005

OFFLU the joint OIE-FAO network of expertise on animal influenza

Alphabet Soup of Flu Strains

SEA/CD/154 Distribution : General. Avian Influenza in South-East Asia Region: Priority Areas for Research

Avian influenza Avian influenza ("bird flu") and the significance of its transmission to humans

Current strategies, initiatives and challenges to mitigate biorisk: Indonesia s experience

Official Journal of the European Union

Evolution of influenza

Introduction to Avian Influenza

Influenza: The past, the present, the (future) pandemic

FAO contribution to the OFFLU swine influenza group


Influenza A virus subtype H5N1

Overview OIE/JTF project on HPAI control in Asia and other related programs by the OIE Asia-Pacific

Final Report for the Outbreak of Highly Pathogenic Avian Influenza (HPAI) in the United States

OIE s initiative on HPAI control

Influenza at the human-animal interface

Outbreaks and control of swine influenza viruses in Korea

M E E T I N G R E P O R T. Expert Group Meeting on Swine Influenza in Asia Pacific Region

Fraser Menzies Veterinary Epidemiology Unit DARD

Recent surveillance of influenza in animals and joint risk assessments

Pannel session on Surveillance of Avian Influenza in Nepal

Avian Influenza: Outbreak in Spring 2015 and Preparing for Fall

Influenza Viruses A Review

The Veterinary Biological Industry and the Production of Human Pandemic Influenza Vaccines in Mexico

Highly Pathogenic Avian Influenza Worldwide situation Larnaca, Cyprus, July 2009

16 th JPC REM ESA M ohammedia 18-19th April Surveillance of low pathogenic Avian Influenza virus

RESEARCH WITH HIGHLY PATHOGENIC AVIAN INFLUENZA H5N1

AI surveillance of domestic birds in Vietnam. Under the OIE/Japan Trust Fund Project (JTF) for Strengthening HPAI Control in Asia,

Countries initially targeted: Bangladesh, Mongolia, Myanmar, Nepal, Lao People s Demoncratic Republic and Pakistan.

Frequently Asked Questions on Avian Influenza

High Pathogenic Avian Influenza

Egypt Success Story In Combating Avian Influenza

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL INTERIM REPORT 02_2013

Influenza and the Poultry Link

Review of Vaccine and Vaccination Component in Global Avian Influenza Control Strategies

Indonesia s challenges and needs in improving national capabilities for disease surveillance, detection and diagnosis and public health systems:

National FMD Response Planning

Introduction. Chapter 7 Protecting Animal Health. Implementation Plan for the National Strategy for Pandemic Influenza 137

Regional Overview of the implementation of National Control Strategies for Avian Influenza. Summary review of questionnaire OIE RRAP

Public Health Responds to Avian Influenza Outbreaks in Commercial Poultry: Lessons from Nigeria

OIE/FAO International Scientific Conference on Avian Influenza OIE Paris, France, 7 8 April 2005 RECOMMENDATIONS

Avian influenza - current situation and future trends

Principles for event based and active avian influenza surveillance. Les Sims Asia Pacific Veterinary Information Services

Current Vaccines: Progress & Challenges. Influenza Vaccine what are the challenges?

Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home

Pandemic Influenza Preparedness

INFLUENZA EVOLUTION: Challenges for diagnosis

Current Status of Highly Pathogenic Avian Influenza in Animal. Wantanee Kalpravidh Food and Agriculture and Organization

Global Challenges of Pandemic and Avian Influenza. 19 December 2006 Keiji Fukuda Global influenza Programme

Avian Influenza. Regional Workshops: Veterinary Discussion. Will Garton

INFLUENZA VIRUS. INFLUENZA VIRUS CDC WEBSITE

Avian Influenza (Bird Flu) Fact Sheet

Should the U.S. develop and stockpile vaccines against A(H5N1) avian flu?

Early Warning, Information Systems and database for the surveillance of Avian Influenza

Global Pandemic Preparedness Research Efforts. Klaus Stöhr. WHO Global Influenza Programme. Today

Surveillance for Avian Influenza in the European Union during EU Reference Laboratory for Avian Influenza, APHA-Weybridge, UK

The role of National Influenza Centres (NICs) during Interpandemic, Pandemic Alert and Pandemic Periods

Broadly protective influenza vaccines for pandemic preparedness. Suresh Mittal Department of Comparative Pathobiology Purdue University

Influenza Pandemic Preparedness for Clinicians on the Frontline

EU REFERENCE LABORATORIES FOR AVIAN INFLUENZA AND NEWCASTLE DISEASE

CAPACITY BUILDING in DETECTION, DIAGNOSIS and CONTAINMENT of INFECTIOUS DISEASE: INDONESIA S EXPERIENCE, CHALLENGES and NEEDS

SURVEILLANCE FOR HIGHLY PATHOGENIC AVIAN INFLUENZA IN MINNESOTA S MIGRATORY BIRDS FROM

xxxx x Taej Mundkur, Ph.D. Flyway Programme Manager Wetlands International Member, Scientific Task Force of Avian Influenza

Mexico H7N3 HPAI Summary

Welsh Government Avian Influenza - Questions & Answers

HIGHLY PATHOGENIC AVIAN INFLUENZA:

Updations on the epidemiological situation of Avian Influenza (AI) in Libya. The 11 th JPC REMESA Algiers, Algeria 24-25November2015

Competing co-infections of LP and HP AIV H7N7

UCD Veterinary Students in the Field

The A(H7N9) influenza outbreak in China

WORLD HEALTH ORGANIZATION

in Vietnam Under the OIE/Japan Trust Fund Project (JTF) for Strengthening HPAI Control Hanoi, 2-3 October 2012

David L. Suarez D.V.M., PhD. A.C.V.M.

U.S. Fish & Wildlife Service Avian Influenza

Biosafety and Bioethics

Research Issues in Animal Surveillance and Pandemic Planning

Guideline for Burial and Cremation

Transcription:

Practical Training Exercise ANALYZING AND MANAGING RISKS IN LIFE SCIENCES RESEARCH Based on the article by Siddique, N. et al. Sequence and phylogenetic analysis of highly pathogenic avian influenza H5N1 viruses isolated during 2006 2008 outbreaks in Pakistan reveals genetic diversity. Virology Journal. 2012; 9: 300. 1

This exercise was developed by Center for Science, Technology and Security Policy at the American Association for the Advancement of Science (AAAS). This work is licensed by AAAS under a Creative Commons Attribution- NonCommercial-ShareAlike 3.0 United States License. You may contact the copyright holder at: 1200 New York Ave. Washington, DC 20002 cstspinfo@aaas.org 1-202-326-6493 This series of case study exercises was developed with input from: Lindsey Marburger, Nisreen AlHmoud, Oussama ben Fradj, Eleanor Celeste, Gwenaële Coat, Cristine Geers, Irene Jillson, Abdulaziz Kaed, Rawan Khasawneh, Fadia Maki, Kimberly Schaub, and Kavita Berger. Developed with the support of the U.S. Department of State s Biosecurity Engagement Program. 2

Learning Objectives 1 Develop the skills to think critically about risks and risk mitigation strategies needed in your own scientific environment; 2 Enhance your ability to identify risk management strategies and approaches that minimize identified risks and maintain the high-quality and utility of the scientific activity; and 3 Apply the risk analysis framework to your own or your peers scientific activities. 3

Participant Expectations By the end of this exercise, you will have familiarity with: 1. The definitions of different types of risks associated with laboratory, field, and public health research. 2. The process of risk analysis risk identification, assessment, management, and communication including: How to identify and assess risks by considering the possible likelihood and consequences of risks, and the risks versus benefits of a research activity, Strategies for managing risks, and Who, when, and how to communicate risks. 3. How to apply the risk analysis framework to your own scientific activities. 4

Ground Rules for Participation Prior to starting this exercise, participants should have read the case study article. Ask the facilitator to clarify questions about the case study article. Focus on understanding and analyzing the diverse risks involved in the research rather than on critiquing the methodologies or research choices of the authors. Interact with one another in a way that encourages open communication and exchange of ideas. For example, listen to everyone s ideas respectfully. You may want to take your own notes to enhance your ability to actively participate in the training activity. 5

Biorisk Glossary These definitions are from the WHO s Responsible Life Science for Global Health Security: A Guidance Document. Responsible Research Spectrum Deliberate Misconduct Negligence and Bad Practice Research Ethics Misuse Theft Environmental Accidental Release Exposure Falsification, Fraud, Plagiarism Animal Subjects Care and Use Human Subjects Research Bioethics Biorisk Biorisk reduction Laboratory biosafety Laboratory biosecurity Dual-use life sciences research Research excellence 6 Additional concepts: Protection of human subjects Protection of animal subjects Responsible research/responsible conduct of research 6

Risk Analysis Framework Your risk review will follow these 4 stages: 1 Risk Identification 2 Risk Assessment 3 Risk Management 4 Risk Communication 7

1. Risk Identification 2. Risk Assessment process by which researchers consider all possible internal, external, and organizational risks. process by which researchers identify needed resources and consider biosafety/biosecurity recommendations. Asks the question: What are the possible risks associated with the research? Also defined as the process of evaluating the risk(s) arising from a hazard(s), taking into account the adequacy of any existing controls and deciding whether or not the risk(s) is acceptable). (OHSAS 18001: 2007) Asks the questions: How likely are the risks to occur? What are the potential consequences if the risks occur? Do the risks outweigh the benefits? 8

3. Risk Management 4. Risk Communication process by which researchers consider regulations/guidelines, training, and SOP compliance issues. Asks the question: What risk management strategies could minimize the likelihood that the risk will occur or the consequences if the risks occurred? Possible strategies: physical barriers, personnel training or vetting, regulations and laws, and/or alternative experiments process by which researchers consider communication strategies, noncompliance issues and approval/modification processes. Asks the questions: What risks should be communicated with ethics or other research review committees prior to project initiation? What risks should be communicated to research participants or fellow researchers during the research project? What risks, if any, might come from sharing research data or results? What strategies could be used to minimize the risks? 9

Risk Analysis Chart 10

CASE STUDY Sequence and phylogenetic analysis of highly pathogenic avian influenza H5N1 viruses isolated during 2006-2008 outbreaks in Pakistan reveals genetic diversity. Siddique, N. et al. Sequence and phylogenetic analysis of highly pathogenic avian influenza H5N1 viruses isolated during 2006 2008 outbreaks in Pakistan reveals genetic diversity. Virology Journal. 2012; 9: 300.

Outline of Case Study Part 1: Research Question/Hypothesis Part 2: Background Information Overview Part 3: Research Methodology Part 4: Risk Analysis in the Research Article Part 5: Research Results and Conclusions 12

Research Question/Hypothesis Research Statement: The present study was designed to carry out sequence and phylogenetic analyses of HPAI H5N1 isolates recovered during 2006 08 from different wild, domestic and commercial poultry populations in Pakistan. The goal is to understand the genetic relationship of Pakistani highly pathogenic H5N1 strains with strains isolated from other parts of the world to better understand the geographic origins of the Pakistani viruses. 13

Background Information Overview Avian Influenza Virus Avian influenza viruses are characterized as highly pathogenic (HPAI) if they cause significant disease in birds. Avian influenza viruses are characterized as low pathogenic (LPAI) if they do not cause disease in birds. HPAI H5N1 viruses originate from Asia. LPAI H5N1 viruses originate from North America. The Asian HPAI and North American LPAI H5N1 strains are not closely related. Influenza A viruses are classified by their hemagglutinin and neuraminidase proteins. Sixteen hemagglutinin (HA) subtypes and 9 neuraminidases (NA) subtypes of Influenza A virus have been identified. 14

Background Information Overview How Influenza Mutates Has 2 surface glycoprotein genes HA hemagglutinin NA neuraminidase Virus undergoes natural mutations Antigenic drift: mutations within individual genome Antigenic shift: exchanging genes between 2 viruses during coinfection (genetic recombination) Influenza Genetic Shift Photo Credit: Wikipedia, 2012 15

Background Information Overview H5N1 in Pakistan The Indus Flyway (an international migratory route) brings 0.7-1.2 million birds to Pakistani wetlands each year. Influenza A viruses have been identified in Pakistani poultry since 1995. HPAI H5N1 was first identified in Pakistan in 2006 (Siddique et al.) Since 2006, HPAI H5N1 infected domestic poultry through backyard interactions with infected wild birds. Vaccination and biosecurity measures were undertaken to control H5N1 circulation in Pakistani birds. Between 2006-2008, only Abbottabad experienced continuous H5N1 infections. HPAI H5N1 outbreaks in Pakistan during 2006 08. Photo Credit: Siddique et al. Photo Credit: Neumann et al., 2010 16

Research Methodology Collection and Isolation. Organs and throat swabs from dead birds were received by provincial surveillance units. Viruses were cultured from samples using fertilized chicken eggs. Allantoic fluid from inoculated embryos was harvested. RNA extraction and genome sequencing. Viral RNA extracted from clinical samples and alliotic fluid using a commercial kit. Real-time PCR was performed to detect H5 virus in the samples and alliotic fluid. Reverse Transcriptase PCR (RT-PCR) was used to create and amplify cdna of the virus. The purified cdna PCR products were sequenced. Phylogenetic analysis. Using the online BLAST algorithm, sequences from the GenBank database that were closely related to the Pakistani H5N1 viral sequences were selected for phylogenetic analysis. The Pakistani H5N1 viral sequences were compared to the selected GenBank H5N1 sequences using commercially available software. 17

Risk Analysis in this Research Article While risk analysis is an important part of science, few scientific publications include in-depth descriptions of how the authors assessed and managed risk. Today your task is to perform a risk analysis based on this research article. To begin, answer the following question: Based on your current knowledge of the experiment procedures and research purpose, what risks might be important to consider in designing, carrying out, or communicating this research? 18

Risk Identification Sequence and phylogenetic analysis of highly pathogenic avian influenza H5N1 viruses isolated during 2006-2008 outbreaks in Pakistan Questions What, if any, are the potential safety risks to researcher and staff? Consider: surveillance teams gathering samples, sample transportation and sample preparation? Does this research pose any potential risks to human health in Pakistan? Can any of this research be used to intentionally harm people or animals? Are there any risks associated with collecting and analyzing samples from wild birds versus a domestic chicken or other livestock? 19

Risk Assessment Sequence and phylogenetic analysis of highly pathogenic avian influenza H5N1 viruses isolated during 2006-2008 outbreaks in Pakistan Question What methodological steps, if any, in this research are most likely to cause a deliberate or accidental incident with severe, negative consequences? How likely is such an incident? What steps in this study present the greatest biosafety threats to the research team? What steps in this study present the greatest biosecurity threats to the research team? How does working with a pathogen of global health concern, such as H5N1, change this assessment? What are the resources, expertise, training, and tools that could be useful in assessing the risks identified for this research project? 20

Risk Management Sequence and phylogenetic analysis of highly pathogenic avian influenza H5N1 viruses isolated during 2006-2008 outbreaks in Pakistan Question Are there any international, domestic, or institutional laws and regulations that would help manage risks from this experiment? What standard operating procedures (SOPs) in sample collection, storage, transport, and analysis should be employed in this research project to mitigate any safety or security risks? How could researchers in this or a similar project minimize potential negative impacts of expected outcomes without changing the research question or the quality of the science? What, if any, specialized competencies, skills, and training are needed to safely and successfully carry out this laboratory experiment? 21

Research Results and Conclusions Results All the HPAI H5N1 viruses in the study were related to those circulating in poultry populations of South Asia, East Asia, Middle East and Europe since late 2005, but Pakistani virus most closely related to those from neighboring countries. Pakistani H5N1 isolates have a high rate of sequence identity, which indicates rapid dissemination throughout the country from a single introduction in Pakistan in 2006. The Pakistani H5N1 isolates from 2006-2008 are genetically diverse, having several mutations in important antigenic and receptor binding sites. Conclusions The Pakistani H5N1 isolates from 2006-2008 were closely related to isolates from Afghanistan and neighboring Eurasian countries. The authors state that that transportation through legal and illegal poultry trade cannot be ignored 22

Risk Communication Sequence and phylogenetic analysis of highly pathogenic avian influenza H5N1 viruses isolated during 2006-2008 outbreaks in Pakistan Question What are the risks that should be communicated during this research? To whom? What are some strategies for communicating the risks and research findings with public and animal health experts and government stakeholders? When working with pathogens of concern to human health or agriculture, SUCH AS H5N1, what tools are available to aid researchers in evaluating the risks of communicating the research findings? Are there any circumstances under which researchers should not share all or some of their findings with other scientists and the public? 23

Final Exercise: Risk in Your Own Research Perform a risk analysis of your own research. Choose one past, ongoing, or future research project to analyze: 1. Identification: What are the primary risks you face in your research? Think about the risks to you and other researchers and technicians in the field, clinic, and/or lab, the general public, the environment and economy, your institution, and human and animal subjects. 2. Assessment: What are the consequences of the identified risks if they occur? How likely are they to occur? Based on your assessment of the potential consequences, are there are there any risks that could harm people, animals, crops, or the economy? What resources, capabilities, and skills are needed to mitigate these risks? 3. Management: What strategies could you use or resources you could refer to minimize or mitigate these risks? (These strategies should not decrease the quality of the research.) For ideas of possible strategies and resources, consider those discussed in this practical exercise and from your own experiences. Are there any risks associated with your research that cannot be adequately mitigated? 4. Communication: What risks, if any, are associated with communicating your research during the design or conduct of the research? What risks, if any, are associated with communicating the research results at scientific conferences and in publications? What strategies could you use to mitigate the risks? Are there any stakeholders with whom you must share or should share the risks of your research? Your findings? 24

Example Risk Analysis Strategy Communicate Laboratory risk management. CWA 15793: 2011 25

Reference List Background Information Siddique, N. et al. Sequence and phylogenetic analysis of highly pathogenic avian influenza H5N1 viruses isolated during 2006 2008 outbreaks in Pakistan reveals genetic diversity. Virology Journal. 2012; 9: 300. Centers for Disease Control and Prevention. Highly Pathogenic Avian Influenza A (H5N1) Virus. Updated June 21, 2012. Available at: http://www.cdc.gov/flu/avianflu/h5n1-virus.htm. U.S. Department of Agriculture. News Release: AVIAN INFLUENZA Low Pathogenic vs. Highly Pathogenic H5N1. Release no. 0296.06. July 23, 2007. Available at: http://www.usda.gov/wps/portal/usda/usdahome?contentidonly=true&contentid=2006/08/0296.xml. World Health Organization, Responsible Life Science for Global Health Security: A Guidance Document. 2010; http://whqlibdoc.who.int/hq/2010/who_hse_gar_bdp_2010.2_eng.pdf. Diagrams and Images European Committee for Standardization (CEN). CEN Workshop Agreement: CWA 15793. Laboratory biorisk management. Ref. No: CWA 15793:2011 D/E/F. September 2011: 17. Available at: ftp://ftp.cenorm.be/cen/sectors/tcandworkshops/workshops/cwa15793_september2011.pdf. Neumann, E., et.al. (2010). 5N1 influenza viruses: outbreaks and biological properties. Cell Research, 20:51 61. Available at: http://www.nature.com/cr/journal/v20/n1/full/cr2009124a.html. Wikipedia. Influenza genetic shift. The Wikipedia Commons. August 18, 2012. Available at: http://en.wikipedia.org/wiki/file:influenza_geneticshift.svg. 26